Tissue-resident macrophages specifically express Lactotransferrin and Vegfc during ear pinna regeneration in spiny mice.

Csf1r Lactotransferrin Vegfc lymphangiogenesis macrophage regeneration resident macrophage spiny mouse wound healing

Journal

Developmental cell
ISSN: 1878-1551
Titre abrégé: Dev Cell
Pays: United States
ID NLM: 101120028

Informations de publication

Date de publication:
10 Jan 2024
Historique:
received: 17 01 2022
revised: 30 05 2023
accepted: 21 12 2023
medline: 17 1 2024
pubmed: 17 1 2024
entrez: 16 1 2024
Statut: aheadofprint

Résumé

The details of how macrophages control different healing trajectories (regeneration vs. scar formation) remain poorly defined. Spiny mice (Acomys spp.) can regenerate external ear pinnae tissue, whereas lab mice (Mus musculus) form scar tissue in response to an identical injury. Here, we used this dual species system to dissect macrophage phenotypes between healing modes. We identified secreted factors from activated Acomys macrophages that induce a pro-regenerative phenotype in fibroblasts from both species. Transcriptional profiling of Acomys macrophages and subsequent in vitro tests identified VEGFC, PDGFA, and Lactotransferrin (LTF) as potential pro-regenerative modulators. Examining macrophages in vivo, we found that Acomys-resident macrophages secreted VEGFC and LTF, whereas Mus macrophages do not. Lastly, we demonstrate the requirement for VEGFC during regeneration and find that interrupting lymphangiogenesis delays blastema and new tissue formation. Together, our results demonstrate that cell-autonomous mechanisms govern how macrophages react to the same stimuli to differentially produce factors that facilitate regeneration.

Identifiants

pubmed: 38228141
pii: S1534-5807(23)00697-4
doi: 10.1016/j.devcel.2023.12.017
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

Copyright © 2024 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of interests At the time of publication, D.T. is employed by Glakosmithkline (GSK).

Auteurs

Jennifer Simkin (J)

Department of Biology, University of Kentucky, Lexington, KY 40506, USA; Department of Orthopaedic Surgery, LSU Health-New Orleans, New Orleans, LA 70112, USA. Electronic address: jsimki@lsuhsc.edu.

Ajoy Aloysius (A)

Department of Biology, University of Kentucky, Lexington, KY 40506, USA.

Mike Adam (M)

Department of Pediatrics, University of Cincinnati Children's Hospital Medical Center, Division of Developmental Biology, Cincinnati, OH 45229, USA.

Fatemeh Safaee (F)

Department of Biology, University of Kentucky, Lexington, KY 40506, USA.

Renée R Donahue (RR)

Department of Biology, University of Kentucky, Lexington, KY 40506, USA.

Shishir Biswas (S)

Department of Biology, University of Kentucky, Lexington, KY 40506, USA.

Zohaib Lakhani (Z)

Department of Orthopaedic Surgery, LSU Health-New Orleans, New Orleans, LA 70112, USA.

John C Gensel (JC)

Department of Physiology, University of Kentucky, Lexington, KY 40506, USA; Spinal Cord and Brain Injury Research Center, University of Kentucky, Lexington, KY 40506, USA.

David Thybert (D)

European Bioinformatics Institute (EMBL-EBI), Cambridge, UK.

Steven Potter (S)

Department of Pediatrics, University of Cincinnati Children's Hospital Medical Center, Division of Developmental Biology, Cincinnati, OH 45229, USA.

Ashley W Seifert (AW)

Department of Biology, University of Kentucky, Lexington, KY 40506, USA; Spinal Cord and Brain Injury Research Center, University of Kentucky, Lexington, KY 40506, USA. Electronic address: awseifert@uky.edu.

Classifications MeSH